Your browser doesn't support javascript.
loading
Recognition of microbial viability via TLR8 drives TFH cell differentiation and vaccine responses.
Ugolini, Matteo; Gerhard, Jenny; Burkert, Sanne; Jensen, Kristoffer Jarlov; Georg, Philipp; Ebner, Friederike; Volkers, Sarah M; Thada, Shruthi; Dietert, Kristina; Bauer, Laura; Schäfer, Alexander; Helbig, Elisa T; Opitz, Bastian; Kurth, Florian; Sur, Saubashya; Dittrich, Nickel; Gaddam, Sumanlatha; Conrad, Melanie L; Benn, Christine S; Blohm, Ulrike; Gruber, Achim D; Hutloff, Andreas; Hartmann, Susanne; Boekschoten, Mark V; Müller, Michael; Jungersen, Gregers; Schumann, Ralf R; Suttorp, Norbert; Sander, Leif E.
Afiliação
  • Ugolini M; Department of Infectious Diseases and Pulmonary Medicine, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Gerhard J; Department of Infectious Diseases and Pulmonary Medicine, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Burkert S; Institute of Microbiology and Hygiene, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Jensen KJ; Research Center for Vitamins and Vaccines, Bandim Health Project, Statens Serum Institut, Copenhagen, Denmark.
  • Georg P; Department of Biotechnology and Biomedicine, Technical University of Denmark, Kgs Lyngby, Denmark.
  • Ebner F; Department of Infectious Diseases and Pulmonary Medicine, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Volkers SM; Department of Veterinary Medicine, Institute of Immunology, Freie Universität Berlin, Berlin, Germany.
  • Thada S; Department of Infectious Diseases and Pulmonary Medicine, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Dietert K; Institute of Microbiology and Hygiene, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Bauer L; Bhagwan Mahavir Medical Research Centre, Hyderabad, India.
  • Schäfer A; Department of Veterinary Medicine, Institute of Veterinary Pathology, Freie Universität Berlin, Berlin, Germany.
  • Helbig ET; Chronic Immune Reactions, German Rheumatism Research Centre, a Leibniz Institute, Berlin, Germany.
  • Opitz B; Institute of Immunology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald-Island of Riems, Germany.
  • Kurth F; Department of Infectious Diseases and Pulmonary Medicine, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Sur S; Department of Infectious Diseases and Pulmonary Medicine, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Dittrich N; German Center for Lung Research (DZL), Berlin, Germany.
  • Gaddam S; Department of Infectious Diseases and Pulmonary Medicine, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Conrad ML; Institute of Microbiology and Hygiene, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Benn CS; Institute of Microbiology and Hygiene, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Blohm U; Bhagwan Mahavir Medical Research Centre, Hyderabad, India.
  • Gruber AD; Department of Genetics, Osmania University, Hyderabad, India.
  • Hutloff A; Department of Internal Medicine and Dermatology, Division of Psychosomatic Medicine, Charite-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
  • Hartmann S; Research Center for Vitamins and Vaccines, Bandim Health Project, Statens Serum Institut, Copenhagen, Denmark.
  • Boekschoten MV; Odense Patient Data Explorative Network (OPEN), Odense University Hospital/Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
  • Müller M; Institute of Immunology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald-Island of Riems, Germany.
  • Jungersen G; Department of Veterinary Medicine, Institute of Veterinary Pathology, Freie Universität Berlin, Berlin, Germany.
  • Schumann RR; Chronic Immune Reactions, German Rheumatism Research Centre, a Leibniz Institute, Berlin, Germany.
  • Suttorp N; Department of Veterinary Medicine, Institute of Immunology, Freie Universität Berlin, Berlin, Germany.
  • Sander LE; Nutrition, Metabolism and Genomics Group, Division of Human Nutrition, Wageningen University, Wageningen, The Netherlands.
Nat Immunol ; 19(4): 386-396, 2018 04.
Article em En | MEDLINE | ID: mdl-29556002
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Atenuadas / Ativação Linfocitária / Linfócitos T Auxiliares-Indutores / Receptor 8 Toll-Like / Viabilidade Microbiana Limite: Adult / Animals / Female / Humans / Male Idioma: En Revista: Nat Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Atenuadas / Ativação Linfocitária / Linfócitos T Auxiliares-Indutores / Receptor 8 Toll-Like / Viabilidade Microbiana Limite: Adult / Animals / Female / Humans / Male Idioma: En Revista: Nat Immunol Assunto da revista: ALERGIA E IMUNOLOGIA Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Estados Unidos